Robert Fulbright

Robert Fulbright, MD, is Professor of Radiology and Biomedical Imaging at Yale School of Medicine with a secondary appointment in Neurology. He serves as Medical Director of the Magnetic Resonance Research Center and specializes in neuroradiology, focusing on diagnostic examinations of the brain, head and neck, spine, and peripheral nervous system using CT, MRI, and MR spectroscopy.

Dr. Fulbright completed his medical degree at Baylor College of Medicine (1984), followed by residency training at Baylor College of Medicine and Columbia University, and a fellowship at Yale University School of Medicine. He is board certified in both Diagnostic Radiology (1991) and Internal Medicine (1988).

His research centers on advanced magnetic resonance techniques to better understand brain function and disease mechanisms, with particular emphasis on Deuterium Metabolic Imaging (DMI) for mapping brain tumor metabolism. His work bridges radiology, neurology, and oncology to improve diagnostic capabilities and patient outcomes.

Analysis of his recent publications (2023-2025) reveals three major research thrusts: metabolic imaging of brain tumors using DMI, genomic correlations with imaging findings in meningiomas, and technical innovations in MRI acquisition and processing. His work demonstrates increasing integration of AI techniques with traditional imaging modalities.

As Medical Director of the Magnetic Resonance Research Center, Dr. Fulbright oversees a multidisciplinary team working at the forefront of neuroimaging technology. His clinical work focuses on neuroradiology with particular expertise in brain tumor imaging and neurological disorders.